Author

K. Gabrusiewicz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Alsuliman· 1 shared A. Heimberger· 1 shared A. K. Nunez Cortes· 1 shared A. L. Gilbert· 1 shared C. Kassab· 1 shared D. Marin· 1 shared D. Yu· 1 shared D. Zamler· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alsuliman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Functional single-cell profiling identifies that exosomes are associated with increased immune cell infiltration in non-metastatic breast cancer

M. Fathi, R. Joseph, J. R. T. Adolacion, M. Martinez-Paniagua, X. An, K. Gabrusiewicz, S. A. Mani, N. Varadarajan

The paper develops a single-cell technique to profile exosome secretion in breast cancer cells and finds that non-metastatic cells secrete more exosomes, which correlates with better prognosis and immune infiltration.

bioRxiv · Dec 14, 2020Cancer Biology

Inhibition of the av integrin-TGF-b axis improves natural killer cell function against glioblastoma stem cells

H. Shaim, M. Hernandez Sanabria, R. Basar, F. Wang, M. Daher, D. Zamler, J. Gumin, K. Gabrusiewicz, Q. Miao, J. Dou, A. Alsuliman, L. Kerbauy, S. Acharya, V. Mohanty, P. Banerjee, , K. Rezvani

The paper shows that inhibiting the integrin-TGF-β axis enhances NK cell function against glioblastoma stem cells, suggesting it as a therapeutic target.

bioRxiv · Mar 30, 2020 · PreprintImmunology